INTRODUCTION
Glare, P., et al. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 2003; 327:195–201.
Kondziolka, D., et al. The accuracy of predicting survival in individual patients with cancer. J Neurosurg 2014; 120:24–30.
Pollan, Michael. In defense of food: An eater’s manifesto. New York: Penguin Press, 2008.
Porter, Roy. The greatest benefit to mankind: A medical history of humanity. 1st American ed. New York: W. W. Norton, 1998.
Silver, Nate. The signal and the noise: Why so many predictions fail—but others don’t. New York: Penguin Press, 2012.
Taleb, Nicholas Nassim. The black swan: The impact of the highly improbable. New York: Random House, 2007.
CHAPTER ONE: PRIMUN NON NOCERE
Albertsen P., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 2005; 97(17):1248–1253.
American Cancer Society. Cancer facts & figures 2013. Atlanta: American Cancer Society, 2013.
Arkes, H., and Gaissmaier, W. Psychological research and the prostate-cancer screening controversy. Psychological Science 2012; 23:547–553.
Berliner, Uri. Tired of gloom and doom? Here’s the best good news of 2013. Morning Edition, National Public Radio, December 24, 2013.
Berner, E., and Graber, M. Overconfidence as a cause of diagnostic error in medicine. Am J Med 2008; 121(5A):S2-S23.
Black, William. Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 2010; 92(16):1280–1282.
Carter, H. B., et al. Early detection of prostate cancer: AUA guideline. American Urological Association, 2013.
Harach, H., et al. Occult papillary carcinoma of the thyroid: A “normal” finding in Finland; A systematic autopsy study. Cancer 1985; 56(3): 531–538.
Haselton, M., and Buss, D. Biases in social judgment: Design flaws or design features? In Responding to the social world: Implicit and explicit processes in social judgments and decisions, ed. J. P. Forgas, K. D. Williams, and W. von Hippel, pp. 23–43. Cambridge: Cambridge University Press, 2013.
Heath, Iona. Overdiagnosis: When good intentions meet vested interests. BMJ 2013; 347:f6361–6363.
Ilic, D., et al. Screening for prostate cancer. Cochrane Database of Syst Rev 2013, Issue 1.
Kahneman, Daniel. Thinking fast and slow. New York: Farrar, Straus, and Giroux, 2011.
Monynihan, R., et al. Preventing overdiagnosis: How to stop harming the healthy. BMJ 2012; 344:e3502–e3508.
Moyer, V. A., and the US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157:120–134.
Rosenhan, D. L. On being sane in insane places. Science 1973; 179 (4070):250–258.
Soos, G., et al. The prevalence of prostate carcinoma and its precursor in Hungary: An autopsy study. Eur Urol 2005; 48(5):739–744.
Spitzer, Robert. On pseudoscience in science, logic in remission, and psychiatric diagnosis: A critique of Rosenhan’s “On being sane in insane places.” J of Abnorm Psychol 1975: 84(5): 442–452.
Spitzer, R., et al. The scientific credibility of Lauren Slater’s pseudopatient diagnosis study. J Nerv Ment Dis 2005; 193:734–739.
Welch, H. Gilbert. Overdiagnosed: Making people sick in the pursuit of health. Boston: Beacon Press, 2011.
Welch, H. G., and Black, W. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102:605–613.
Wiener, R. S., et al. When a test is too good: How CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 2013; 347:f3368-f3375.
CHAPTER TWO: VIGNETTE
Mlodinow, Leonard. The drunkard’s walk: How randomness rules our lives. New York: Pantheon Books, 2008.
CHAPTER THREE: SNOWBALL IN A BLIZZARD
American Cancer Society. Breast cancer facts & figures 2011–12. Atlanta: American Cancer Society, 2012.
Bassett, L., and Gold, R. The evolution of mammography. AJR 1988; 150; 493–498.
Caplan, Arthur. “Mammogram advice accurate but not ‘right.’” NBCNews.com, November 19, 2009. http://www.nbcnews.com/id/34040273/ns/health-cancer/t/mammogram-advice-accurate-not-right/#.VZhGllLbJMs, retrieved July 2015.
Elmore, J., et al. Screening mammograms by community radiologists: Variability in false-positive rates. J Natl Cancer Inst 2002; 94(18): 1373–1380.
Feld, Ellen. A doctor discovers a patient in the mirror. New York Times, July 19, 2010.
———. Finding little comfort in the statistics of survival. New York Times, October 17, 2011.
Fletcher, Suzanne. Whither scientific deliberation in health policy recommendations?—Alice in the Wonderland of breast cancer screening. N Engl J Med 1997; 336:1180–1183.
Gøtzsche, P. C., and Nielsen, M. Screening for breast cancer with mammography. Cochrane Database of Syst Rev 2011, Issue 4.
Jørgensen, K., and Gøtzsche, P. C. Overdiagnosis in publicly organised mammography screening programmes: Systematic review of incidence trends. BMJ 2009; 339:b2587-b2595.
Kerlikowske, Karla. Screening mammography in women less than age 50 years. Curr Opin Obstet Gynecol 2012; 24:38–43.
Kolata, Gina. Mammogram debate took group by surprise. New York Times, November 20, 2009.
———. Vast study casts doubt on value of mammograms. New York Times, February 11, 2014.
Lobo, Roger. Where are we 10 years after the Women’s Health Initiative? J Clin Endocrinol Metab 2013; 98:1771–1780.
Major cancer agencies respond to USPSTF’s new mammography guidelines. Oncology, December 15, 2009. http://www.cancernetwork.com/oncology-journal/major-cancer-agencies-respond-uspstf%E2%80%99s-new-mammography-guidelines, retrieved July 2015.
Mandelblatt, J., et al. for the Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET). Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms. Ann Intern Med 2009; 151:738–747.
Miller, A., et al. Twenty-five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: Randomised screening trial. BMJ 2014; 348:g366–g376.
Nyström, L., et al. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 2002; 359:909–919.
Pace, L., et al. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 2013; 119:2518–2523.
Rabin, Roni Caryn. New guidelines on breast cancer draw opposition. New York Times, November 16, 2009.
Saul, Stephanie. Prone to error: Earliest steps to find cancer. New York Times, July 19, 2010.
Shapiro, Sam. Evidence on screening for breast cancer from a randomized trial. Cancer 1977; 39:2772–2782.
Susan G. Komen for the Cure. Facts for life: Breast cancer detection. http://ww5.komen.org/uploadedFiles/_Komen/Content/About_Breast_Cancer/Tools_and_Resources/Fact_Sheets_and_Breast_Self_Awareness_Cards/BreastCancerDetection.pdf. Retrieved July 2014; updated version retrieved July 2015.
US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151:716–726.
Zahl, P. H., et al. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: Prospective cohort study. BMJ 2004; 328:921–924.
CHAPTER FOUR: THE PRESSURES OF MANAGING PRESSURE
Gibbons, G., et al. Refocusing the agenda on cardiovascular guidelines: An announcement from the National Heart, Lung, and Blood Institute. Circulation 2013; 128(15):1713–1715.
Husten, Larry. The heart guidelines are dead: Long live the heart guidelines. Forbes, August 9, 2013.
———. Minority report: Five guideline authors reject change in blood pressure goal. Forbes, January 13, 2014.
James, P., et al. Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC8). JAMA 2014; 311(5):507–520.
Moser, M., et al. Report of the Joint National Committee on the detection, evaluation, and treatment of high blood pressure: A cooperative study. JAMA 1977; 237(3):255–261.
Myers, M. and Tobe, S. A. Canadian perspective on the Eighth Joint National Committee (JNC8) hypertension guidelines. J Clin Hypertens 2014; 16(4):246–248.
Navar-Boggan, A., et al. Proportion of US adults potentially affected by the 2014 hypertension guideline. JAMA 2014; 311(14):1424–1429.
Peterson, E., et al. Recommendations for treating hypertension: What are the right goals and purposes? JAMA 2014; 311(5):474–476.
SHEP Cooperative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255–3264.
Wright, J., et al. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: The minority view. Ann Int Med 2014; 160(7):499–503.
CHAPTER FIVE: LYME’S FALSE PROPHETS
Asher, Tammy. Unprecedented antitrust investigation into the Lyme disease treatment guidelines development process. Gonzaga Law Rev 2011; 46:117–145.
Blumenthal, Richard. Attorney general’s investigation reveals flawed Lyme disease guideline process, IDSA agrees to reassess guidelines, install independent arbiter. Office of the Attorney General of the State of Connecticut, press release, May 1, 2008.
Brody, Jane. A threat in a grassy stroll. New York Times, July 15, 2008. cave76. Stricker’s alleged scientific misconduct. Lymenet Europe, January 27, 2008. http://www.lymeneteurope.org/forum/viewtopic.php?f=7&t=627&sid=f5c5d5cbd75745be96847bcd6158ce80&start=10.
Centers for Disease Control and Prevention. Other types of laboratory testing. http://www.cdc.gov/lyme/diagnosistesting/labtest/otherlab/index.html, accessed July 2015.
Chang, Kenneth. Paleontology and creationism meet but don’t mesh. New York Times, June 29, 2009.
Cressey, Daniel. XMRV paper withdrawn. Nature (blog), December 22, 2011.
Feder, H., et al. A critical appraisal of chronic Lyme disease. N Engl J Med 2007; 357:1422–1430.
International Lyme and Associated Diseases Society (ILADS). Basic information about Lyme disease. http://www.ilads.org/lyme/about-lyme.php, retrieved July 2015.
Klein, Jerome. Danger ahead: Politics intrude in Infectious Diseases Society of America guideline for Lyme disease. Clin Inf Dis 2008; 47:1197–1199.
Klempner, M., et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345:85–92.
Landers, Susan. Lyme disease debate provokes treatment divide, legal action. American Medical News, December 25, 2006.
Lantos, P., et al. Final report of the Lyme Disease Review Panel of the Infectious Diseases Society of America (IDSA). Clin Inf Dis 2010; 51(1):1–5.
Levin Becker, Arielle. Blumenthal takes Lyme disease fight to the Senate. CT Mirror, July 18, 2011.
National Institutes of Health, Office of Research Integrity. Final findings of scientific misconduct. http://grants.nih.gov/grants/guide/notice-files/not93–177.html, retrieved July 2015.
Stricker, R., and Johnson, L. Chronic Lyme disease and the “Axis of Evil.” Future Microbiol 2008; 3(6):621–624.
———. Lyme disease: The next decade. Infect Drug Resist 2011; 4:1–9.
Whelan, David. Lyme, Inc.: Ticks aren’t the only parasites living off patients in borreliosis-prone areas. Forbes, February 23, 2007.
Wormser, G., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Inf Dis 2006; 43:1089–1134.
———. A limitation of 2-stage serological testing for Lyme disease: Enzyme immunoassay and immunoblot assay are not independent tests. Clin Infect Dis 2000; 30(3):545–548.
CHAPTER SIX: THE ORIGINS OF KNOWLEDGE AND THE SEEDS OF UNCERTAINTY
Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376:1670–1681.
Downs, J., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998; 279:1615–1622.
Dunn, Peter. James Lind (1716–94) of Edinburgh and the treatment of scurvy. Arch Dis Child Fetal Neonatal Ed 1997; 76:F64-F65.
Endo, Akira. The origin of statins. Atheroscler Suppl 2004; 5(3):125–130.
Finegold, J., et al. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. Eur J Prev Cardiol 2014; 21(4):464–474.
Frick, M. H., et al. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317(20):1237–1245.
General Nutrition Centers, Inc. GNC men’s saw palmetto formula. http://www.gnc.com/GNC-Mens-Saw-Palmetto-Formula/product.jsp?productId=13088264, retrieved July 2015.
Gilbody, S. M., House, A. O., and Sheldon, T. A. Psychiatrists in the UK do not use outcomes measures: National survey. Br J Psychiatry 2002; 180:101.
Jeger, R., and Dieterle, T. Statins: Have we found the Holy Grail? Swiss Med Wkly 2012; 142:w13515.
Johnson, Linda. Against odds, Lipitor became world’s top seller. USA Today, December 28, 2011.
Kramer, Peter. Listening to Prozac. New York: Viking, 1993.
Lipid Clinics Research Program. The Lipid Research Clinics coronary primary prevention trial results. JAMA 1984; 251:351–364.
Mark, T. L., et al. Datapoints: Psychotropic drug prescriptions by medical specialty. Psychiatr Serv 2009; 60(9):1167.
Maron, D., et al. Current perspectives on statins. Circulation 2000; 101(2):207–213.
Mojtabai, R., and Olfson, M. National patterns in antidepressant treatment by psychiatrists and general medical providers: Results from the national comorbidity survey replication. J Clin Psychiatry 2008; 69(7):1064–1074.
Pencina, M., et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med 2014; 370:1422–1431.
Pratt, L., et al. Antidepressant use in persons aged 12 and over: United States, 2005–2008. Centers for Disease Control NCHS Data Brief 2011; 76:1–8.
Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994; 344(8934):1383–1389.
Shepherd, J., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301–1307.
Stone, N., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129(25 Supp 2):S1–S45.
Thompson, Warren. Cholesterol: Myth or reality? Southern Med Jrnl 1990; 83(4):435–440.
Tobert, Jonathan. Efficacy and long-term adverse effect pattern of lovastatin. Am J Cardiol 1988; 62:28J–34J.
Turner, E., et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358(3):252–260.
Witzum, J. L. Current approaches to drug therapy for the hypercholesterolemic patient. Circulation 1989; 80:1101–1114.
Wong, D., et al. The discovery of fluoxetine hydrochloride (Prozac). Nat Rev Drug Discov 2005; 4(9):764–774.
Wurtzel, Elizabeth. Prozac nation: Young and depressed in America. Boston: Houghton-Mifflin, 1994.
CHAPTER SEVEN: THE CORRELATION / CAUSATION PROBLEM
Bakalar, Nicholas. In one study, a heart benefit for chocolate. New York Times, September 14, 2009.
Baylin, A., et al. Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology 2006; 17(5):506–511.
Bouchez, C. HRT: Revisiting the hormone decision. WebMD, http://www.webmd.com/menopause/features/hrt-revisiting-the-hormone-decision, retrieved July 2015.
Centers for Disease Control and Prevention. Pneumocystis pneumonia—Los Angeles. MMWR Morb Mortal Wkly Rep 1981; 30(21):250–252.
Chang, Louise. Coffee may trigger heart attack. WebMD Health News, August 15, 2006. http://www.webmd.com/heart-disease/news/20060815/coffee-may-trigger-heart-attack, retrieved July 2015.
Evans, David. Pfizer broke the law by promoting drugs for unapproved uses. Bloomberg, November 9, 2009.
Herbst, Arthur. Interview on 40th anniversary of publication of DES paper. The University of Chicago. https://www.youtube.com/watch?v=doSpbfDcJHc, retrieved July 2015.
Herbst, A., et al. Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. New England Journal of Medicine 1971; 284(16):878–881.
Herbst, A., and Scully, R. Adenocarcinoma of the vagina in adolescence: A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 1970; 25(4):745–757.
Hulley, S., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998; 280:605–613.
Janszky, I., et al. Chocolate consumption and mortality following a first acute myocardial infarction: The Stockholm Heart Epidemiology Program. J Intern Med 2009; 266(3):248–257.
Kolata, Gina. Citing risks, U.S. will halt study of drugs for hormones. New York Times, July 9, 2002.
Kolata, G., and Petersen, M. Hormone replacement study a shock to the system. New York Times, July 10, 2002.
Lobo, Roger. Where are we 10 years after the Women’s Health Initiative? J Clin Endocrinol Metab 2013; 98:1771–1780.
Nelson, H., et al. Menopausal hormone therapy for the primary prevention of chronic conditions: A systematic review to update the U.S. Preventive Services Task Force recommendations. Ann Intern Med 2012; 157:104–113.
Newell, G., et al. Toxicity, immunosuppressive effects and carcinogenic potential of volatile nitrites: Possible relationship to Kaposi’s sarcoma. Pharmacotherapy 1984; 4(5):284–291.
Petersen, Molly. Wyeth stock falls 24% after report. New York Times, July 10, 2002.
Smith, D., et al. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975; 293(23):1164–1167.
Sommers, N., and Ridgeway, J. Can a woman be feminine forever? New Republic, March 19, 1966.
Wilson, Robert. Feminine forever. New York: M. Evans, 1966.
CHAPTER EIGHT: “HEALTH WATCH”
Arnheim-Dahlström, L., et al. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: Cohort study. BMJ 2013; 347:f5906–f5916.
Brainard, Curtis. Mixed grades for medical coverage. Columbia Journalism Review, April 22, 2011, http://www.cjr.org/the_observatory/mixed_grades_for_med_coverage.php, retrieved July 2015.
Ceccarelli, Leah. Manufactroversy: The art of creating controversy where none existed. Science Progress, April 11, 2008.
Couric, Katie. Furthering the conversation on the HPV vaccine. Huffington Post, December 10, 2013. http://www.huffingtonpost.com/katie-couric/vaccine-hpv-furthering-conversation_b_4418568.html, retrieved July 2015.
———. The HPV vaccine controversy. Katie, December 4, 2013. The full episode is now no longer accessible, as the Katie website was taken down during the writing of this book. A portion of the show remains on YouTube: https://www.youtube.com/watch?v=DjJd2hK76ZY, retrieved July 2015.
Fox, Maggie. German doctors declare “cure” in HIV patient. Reuters, December 15, 2010. http://www.reuters.com/article/2010/12/15/us-aids-transplant-idUSTRE6BE68220101215, retrieved July 2015.
Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915–1927.
Jaslow, Ryan. Katie Couric show on HPV vaccine sparks backlash. CBS News, December 5, 2013. http://www.cbsnews.com/news/katie-couric-show-on-hpv-vaccine-sparks-backlash/, retrieved July 2015.
Mnookin, Seth. The panic virus: A true story of medicine, science, and fear. New York: Simon & Schuster, 2011.
Orac. H1N1 vaccine and miscarriages: More dumpster diving in the VAERS database. ScienceBlogs, November 28, 2012. http://scienceblogs.com/insolence/2012/11/28/h1n1-vaccine-and-miscarriages-more-antivaccine-fear-mongering-about-flu-vaccines/, retrieved July 2015.
———. Katie Couric on the HPV vaccine: Antivaccine or irresponsible journalist? You be the judge! ScienceBlogs, December 5, 2013. http://scienceblogs.com/insolence/2013/12/05/katie-couric-on-the-hpv-vaccine-antivaccine-or-irresponsible-journalist-you-be-the-judge/, retrieved July 2015. Includes links to the Katie episode as well as interviews with others.
Reynolds, Gretchen. Can you get too much exercise? New York Times, July 24, 2013.
Schwitzer, Gary. How do US journalists cover treatments, tests, products, and procedures? PLoS Med 2008; 5(5):e95.
Schwitzer, G., et al. HealthNewsReview: Your health news watchdog. http://www.healthnewsreview.org/, retrieved July 2015.
--. To build a knee: Done right, it’s fast, safe, and effective. HealthNewsReview, http://www.healthnewsreview.org/review/976/, retrieved July 2015.
Siegel, Marc. False alarm: The truth about the epidemic of fear. Hoboken, NJ: John Wiley & Sons, 2005.
US Department of Health and Human Services. Vaccine adverse event reporting system. https://vaers.hhs.gov/index, retrieved July 2015. The database for the 2013 reports can be found at this website.
CHAPTER NINE: CONCLUSION
Allen, Arthur. Vaccine: The controversial story of medicine’s greatest lifesaver. New York: W. W. Norton, 2007.
American College of Radiology. USPSTF breast cancer screening recommendations would cost thousands of lives and could eliminate mammography insurance coverage for millions of women, press release, April 20, 2015. http://www.acr.org/About-Us/Media-Center/Press-Releases/2015-Press-Releases/20150420-Draft-USPSTF-Breast-Cancer-Screening-Recommendations-Would-Cost-Thousands-of-Lives, retrieved July 2015.
Bernard, S., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346:557–563.
Blagden, S. P., et al. Performance status score: Do patients and their oncologists agree? Brit J Cancer 2003; 89:1022–1027.
Friedewald, S., et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 2014; 311(24):2499–2507.
Glare, Paul. Clinical predictors of survival in advanced cancer. J Support Oncol 2005; 3:331–339.
Harris, Gail. Family-centered rounds in the neonatal intensive care unit. Nursing for Women’s Health 2014; 18(1):20–27.
Jacobowski, N., et al. Communication in critical care: Family rounds in the intensive care unit. Am J Crit Care 2010; 19:421–430.
Jauhar, Sandeep. When doctors need to lie. New York Times, February 22, 2014.
Kitch, Barrett. Inviting families to daily ICU work rounds. Massachusetts Board of Registration in Medicine Newsletter, January 2014.
Offit, Paul. Autism’s false prophets: Bad science, risky medicine, and the search for a cure. New York: Columbia University Press, 2008.
Schiller, W., and Anderson, B. Family as a member of the trauma rounds: A strategy for maximized communication. J Trauma Nurs 2003; 10(4):93–101.
Schwitzer, Gary. Which journalists reported an extra dimension on the 3-D mammography story? HealthNewsReview, June 25, 2014. http://www.healthnewsreview.org/2014/06/who-reported-an-extra-dimension-of-the-3-d-mammography-story/, retrieved July 2015.
Whitney, C., et al. Benefits from immunization during the Vaccines for Children Program era—United States, 1994–2013. MMWR Morb Mortal Wkly Rep 2014; 63(16):352–355.
APPENDIX
Christensen, Jen. Bee, scorpion and snake venom may hold cancer cure. CNN, August 12, 2014. http://edition.cnn.com/2014/08/12/health/venom-nanotechnology-cancer/, retrieved July 2015.
Crofton, J. The MRC randomized trial of streptomycin and its legacy: A view from the clinical front line. J R Soc Med 2006; 99:531–534.
Doll, R., and Hill, A. B. A study of the aetiology of carcinoma of the lung. BMJ 1952; 2:1271–1286.
Gordis, Leon. Epidemiology, 4th ed. Philadelphia: Elsevier/Saunders, 2009.
Larke, N., et al. Male circumcision and penile cancer: A systematic review and meta-analysis. Cancer Causes Control 2011; 22:1097–1110.
Marshall, G., et al. Streptomycin treatment of pulmonary tuberculosis. BMJ 1948; October 30:769–782.
National Lung Screening Trial Research Team. The National Lung Screening Trial: Overview and study design. Radiology 2011; 258(1):243–253.
O’Brien, S., et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348:994–1004.
Stolley, Paul. When genius errs: R. A. Fisher and the lung cancer controversy. Am J Epidemiol 1991; 133(5):416–425.
Whelan, Charles. Naked statistics: Stripping the dread from the data. New York: W. W. Norton, 2013.